Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approach

Thrombosis and Haemostasis

Volumn 83, Issue 1, 2000, Pages 165-170

  Suttnar, Jiří ^a   Dyr, Jan E ^a   Dolečková, Lucie ^b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Hydropathic complementarity; Thrombin receptor

Indexed keywords

BRADYKININ DERIVATIVE; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ARTICLE; BINDING SITE; COMPUTER PROGRAM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0033969081     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613773     Document Type: Article

References (29)

1. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-66.
2. Coller BS, Ward P, Ceruso M, Scudder LE, Springer V, Kutok J, Prestwich GD. Thromhin receptor activating peptides: Importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry 1992; 31: 11713-20.
3. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313: 353-68.
4. Rasmussen UB, Gachet C, Schlezinger Y, Hanau D, Ohlmann P, van Obberghen-Schilling E, Pouysségur J, Cazenave J-P, Pavirani A. A peptide ligand of the human thrombin receptor antagonizes α-thrombin and partially activates platelets. J Biol Chem 1993; 268: 14322-8.
5. Chao BH, Kalkunte S, Maraganore JM, Stone SR. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry 1992; 31: 6175-8.
6. Furman MI, Liu L, Benoit SE, Becker RC, Barnard MR, Michelson AD. The cleaved peptide of the thrombin receptor is a strong platelet agonist. Proc Natl Acad Sci USA 1998; 95: 3082-7.
7. Hasan AAK, Amenta S, Schmaier AH. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe are selective inhibitors of α-thrombin-induced platelet activation. Circulation 1996; 94: 517-28.
8. Nanevicz T, Wang L, Chen M, Ishii M, Coughlin SR. Thrombin receptor activation mutations. J Biol Chem 1996; 271: 702-6.
9. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanewitz T, Turck CW, Vu TKH, Coughlin SR. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 1994; 368: 648-51.
10. Bahou WF, Kutok JL, Wong A, Potter CL, Coller BS. Identification of a novel thrombin receptor sequence required for activation-dependent responses. Blood 1994; 84: 4195-202.
11. Scott JK, Craig L. Random peptide libraries. Cur Op Biotechnol 1994; 5: 40-8.
12. Mandell AJ, Owens MJ, Selz KA, Morgan WN, Shlesinger MF, Nemeroff CB. Mode matches free energy eigenfunctions predict peptide-protein interactions. Biopolymers 1998; 46: 89-101.
13. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32.
14. Blalock JE, Smith EM. Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem Biophys Res Comm 1984; 121: 203-7.
15. Bost KL, Smith EM, Blalock JE. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci 1985; 82: 1372-5.
16. Blalock JE, Bost KL. Binding of peptides that are specified by complementary RNAs. Biochem J 1986; 234: 679-83.
17. Blalock JE. Complementarity of peptides specified by "sense" and "antisense" strands of DNA. Trends Biotech 1991; 6: 140-4.
18. Trospha A, Kizer JS, Chaiken IM. Making sense from antisense: a review of experimental data and developing ideas on sense-antisense peptide recognition. J Molec Recognition 1992; 5: 43-54.
19. Bost KL, Blalock JE. Preparation and use of complementary peptides. In: Methods in Enzymology. Conn M, ed. New York 1989; 168: 16-28.
20. Fassina G, Thorgeirsson SS, Omichinski, JG. Sequence directed design of recognition peptides. In: Methods in protein sequence analysis. Wittimann-Liebold B, ed. Berlin: Springer Verlag 1989; 431-8.
21. Fassina G, Roller PR, Oison AD, Thorgeirsson SS, Omichinski JG. Recognition properties of peptides hydropathically complementary to residues 356-375 of the c-raf protein. J Biol Chem 1989; 264: 11252-7.
22. Fassina G, Cassani G. Design and recognition properties of a hydropathically complementary peptide to human interleukin 1b. Biochem J 1992; 282: 773-9.
23. Fassina G, Consonni R, Zetta L, Cassani G. Design of hydropathically complementary peptides for Big Endothelin affinity purification. Int J Peptide Protein Res 1992; 39: 540-8.
24. Suttnar J, Dyr JE. The complementary hydropathy relation of the alpha-thrombin ihibitory sequence of bradykinin and its analogues to platelet thrombin receptor. Thromb Haemost 1997; Supplement: PS-264.
25. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
26. Fox JEB, Reynolds CC, Boyles JK. Studying the Platelet Cytoskeleton in Triton X-100 Lysates. In: Methods in Enzymology. Hawiger JJ, ed. San Diego, California: Academic Press 1992; 215: 44-5.
27. Ramachandran R, Klufas AS, Molino M, Ahuja M, Hoxie JA, Brass LF. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin. Thromb Haemost 1997; 78: 1119-24.
28. Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nature Med 1995; 1: 894-901.
29. Bernstein RSR, Holsworth DD. Antisense peptides: a critical mini-rewiev. J Theor Biol 1998; 190: 107-19.